Filana Therapeutics, Inc. (FLNA) — Financial Flexibility Index

Latest as of December 2025: -0.21x

Filana Therapeutics, Inc. (FLNA) has a Financial Flexibility Index of -0.21x as of December 2025. Free cash flow of $-9.25 Million (operating CF $-9.75 Million minus capex $501.00K) represents 0% of total liabilities ($43.95 Million). Also explore net asset growth rate of Filana Therapeutics, Inc. to track the company's year-over-year net asset growth rate.

Financial Flexibility Index

-0.21x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-9.25 Million
Operating CF − Capex

Total Liabilities

$43.95 Million
USD

Capital Expenditures

$501.00K
USD

Filana Therapeutics, Inc. Financial Flexibility Index (2022–2025)

Historical Financial Flexibility Index trend for Filana Therapeutics, Inc. across 4 annual periods. See Filana Therapeutics, Inc. (FLNA) balance sheet quality index to measure how much of total assets are equity-financed.

Annual Financial Flexibility Index for Filana Therapeutics, Inc. (2022–2025)

Year-by-year free cash flow to debt coverage for Filana Therapeutics, Inc.. For the full company profile including market capitalisation, see FLNA company net worth.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2025 -0.72x $-31.67 Million $-32.25 Million $43.95 Million ▲ +92.7%
2024 -9.88x $-116.83 Million $-116.93 Million $11.83 Million ▼ -71.8%
2023 -5.75x $-81.61 Million $-82.03 Million $14.20 Million ▲ +43.9%
2022 -10.25x $-74.80 Million $-77.51 Million $7.29 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities